Valued at USD 251.28 million in 2023, the global Acupuncture Needles market is projected to reach USD 258.68 million in 2024 and USD 372.40 million by 2032, growing at a CAGR of 4.7% during the forecast period 2024–2032, as reported by Polaris Market Research. Major participants include 3B Scientific GmbH, AcuMedic Ltd., asia-med GmbH, SEIRIN, Dana Medical Co., Suzhou Hualun Medical Appliance Co., Boen Healthcare Co., Wuxi Jiajian Medical Devices Co., and Suzhou Zhongjing Life Science Technology Co. Material choices and regional dynamics are shaping competitive positioning.

Material Segmentation in the Acupuncture Needles Market

The market is segmented by material into stainless steel, gold, and silver. Silver needles are expected to hold a significant market share by 2032 and to experience a moderate growth rate over the forecast period. Their high thermal conductivity produces an efficient thermal effect in warm acupuncture procedures, and they provide patients with greater and quicker relief than other materials. Patient demand for silver needles has recently increased as a result. However, the limited number of market participants supplying this product and the high cost of the material may impede segment growth. Stainless steel and gold complete the material segmentation, and the report analyzes each material by region through 2032.

Reusable Products Face Safety Headwinds

Non-disposable needles are expected to expand at a moderate rate over the forecast period. The high danger of disease transmission from patient to patient is identified as a main drawback that accounts for the product’s low material rate. By contrast, the report notes that disposable products held the largest share in 2022, and it lists infection risk from reusable needles among market restraints. End-use segments include hospitals, clinics, and others.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/acupuncture-needles-market

Asia Pacific Leads the Acupuncture Needles Market

Asia Pacific led the Acupuncture Needles Market in 2022 and is anticipated to experience the fastest growth rate over the forecast period. The presence of developing nations such as China, India, and Japan is expected to accelerate regional development. Acupuncture is a popular traditional Chinese medicine option in both China and Japan. The rapidly expanding medical tourism business in these nations also contributes to rising demand for acupuncture treatments, and the report references data on India’s export of health services from the Directorate-General of Commercial Intelligence and Statistics. The report also covers North America, Europe, Latin America, and the Middle East and Africa, with country-level analysis for markets such as the U.S., Germany, and Brazil.

Demand Drivers Across Regions

Growth drivers cited in the report include the rise in chronic diseases such as diabetes, obesity, and autoimmune conditions, a growing elderly population, and increased adoption of acupuncture for pain management. WHO data referenced in the report put the number of people with hypertension at 1.13 billion in 2021. Rising demand for acupuncture treatments has also led many local companies to enter the market.

Clinical Evidence Strengthens Adoption

Recent research supports clinical use. In October 2024, a comprehensive systematic review in PAIN Reports outlined the neurobiological mechanisms underlying acupuncture-induced analgesia, reinforcing the scientific evidence for its use in both acute and chronic clinical conditions. In March 2025, a case report published in Medicine described complete lesion resolution in an elderly patient with herpes zoster following four sessions of subcutaneous acupuncture, with no postherpetic neuralgia observed at a 12-month follow-up.

Regulatory Enforcement and Competitive Implications

Regulatory scrutiny is a relevant consideration for suppliers. In January 2025, the FDA released a warning letter to Robbins Instruments over the marketing of its Dermo-Jet needle-free injector without appropriate regulatory clearance, highlighting the agency’s strict enforcement approach toward acupuncture-related medical devices. The report profiles nine leading companies, including 3B Scientific, SEIRIN, and Dana Medical Co., within its competitive landscape.

Conclusion

As the Acupuncture Needles Market grows from USD 258.68 million in 2024 to USD 372.40 million by 2032, Asia Pacific’s leadership, material innovation, and growing clinical evidence will remain central themes for manufacturers and healthcare buyers.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market